BILLIRT AMBE: Open Payments
NPI 1790049419 · MARTINSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 18 payments from 8 companies in 2025. Trend: 2023 $84 · 2024 $395 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $119 |
| ABBVIE INC. | 3 | $73 |
| Janssen Pharmaceuticals, Inc | 3 | $65 |
| Alkermes, Inc. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: INGREZZA, VRAYLAR, CAPLYTA, INVEGA SUSTENNA, ARISTADA, AUSTEDO XR, SPRAVATO, LYBALVI.
Industry payments across WV — which companies pay providers there.
